Ming-Rong Zhang Selected Research

Ming-Rong Zhang Research Topics

Disease

56	Neoplasms (Cancer) 06/2022 - 10/2009
27	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 04/2004
17	Neuroinflammatory Diseases 01/2022 - 11/2007
14	Breast Neoplasms (Breast Cancer) 06/2022 - 04/2009
9	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2022 - 11/2007
9	Inflammation (Inflammations) 01/2021 - 07/2009
8	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022 - 01/2013
8	Hypoxia (Hypoxemia) 05/2022 - 09/2015
8	Central Nervous System Diseases (CNS Diseases) 01/2022 - 10/2012
8	Tauopathies 10/2020 - 03/2011
6	Neoplasm Metastasis (Metastasis) 06/2022 - 10/2014
6	Cognitive Dysfunction 01/2022 - 01/2016
5	Melanoma (Melanoma, Malignant) 01/2021 - 10/2014
5	Ischemia 01/2021 - 06/2010
5	Schizophrenia (Dementia Praecox) 01/2020 - 01/2017
5	Dementia (Dementias) 01/2019 - 04/2005
4	Brain Neoplasms (Brain Tumor) 05/2022 - 01/2007
4	Brain Diseases (Brain Disorder) 01/2020 - 04/2004
4	Human Influenza (Influenza) 01/2014 - 02/2008
3	Major Depressive Disorder (Major Depressive Disorders) 10/2021 - 04/2014
3	Carcinoma (Carcinomatosis) 08/2020 - 01/2015
3	Parkinson Disease (Parkinson's Disease) 06/2020 - 01/2016
3	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2018
3	Nervous System Diseases (Neurological Disorders) 01/2020 - 01/2012
3	Glioblastoma (Glioblastoma Multiforme) 09/2019 - 01/2016
3	Lung Neoplasms (Lung Cancer) 12/2018 - 04/2011
3	Mental Disorders (Mental Disorder) 06/2018 - 02/2009
3	Pneumonia (Pneumonitis) 01/2016 - 09/2011
3	Amyloid Plaque 12/2015 - 09/2013
3	Brain Injuries (Brain Injury) 06/2014 - 11/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 11/2015
2	Atherosclerosis 10/2021 - 08/2018
2	Stroke (Strokes) 01/2021 - 06/2014
2	Epilepsy (Aura) 01/2020 - 09/2018
2	Atrophy 01/2020 - 03/2011
2	Obesity 01/2019 - 01/2016
2	Experimental Arthritis 11/2018 - 01/2018
2	Body Weight (Weight, Body) 06/2018 - 01/2017

Drug/Important Bio-Agent (IBA)

41	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2007
25	LigandsIBA 10/2021 - 04/2004
21	Pharmaceutical PreparationsIBA 01/2022 - 02/2008
18	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2008
12	Peptides (Polypeptides)IBA 01/2022 - 03/2011
12	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2020 - 04/2009
11	Amyloid (Amyloid Fibrils)IBA 01/2022 - 03/2011
8	GABA-A Receptors (GABA(A) Receptor)IBA 01/2010 - 04/2004
7	metabotropic glutamate receptor type 1IBA 01/2020 - 10/2012
7	Glutamic Acid (Glutamate)FDA Link 01/2019 - 02/2009
7	AcidsIBA 12/2018 - 01/2011
6	IntegrinsIBA 12/2020 - 04/2014
5	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 11/2020 - 11/2013
4	ErbB Receptors (EGF Receptor)IBA 07/2022 - 09/2021
4	AntibodiesIBA 05/2022 - 11/2012
4	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 05/2022 - 09/2014
4	Biological ProductsIBA 01/2022 - 08/2014
4	pyridineIBA 07/2021 - 10/2014
4	RadiopharmaceuticalsIBA 01/2021 - 01/2018
4	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020 - 10/2012
4	cyclic arginine-glycine-aspartic acid peptideIBA 06/2018 - 04/2014
4	AcetylcholinesteraseIBA 01/2018 - 04/2005
4	acetamideIBA 11/2017 - 10/2009
4	Oseltamivir (Tamiflu)FDA Link 01/2014 - 02/2008
3	Monoacylglycerol LipasesIBA 01/2022 - 10/2019
3	Cetuximab (Erbitux)FDA Link 10/2021 - 06/2018
3	N- benzyl- N- methyl- 2- (7,8- dihydro- 7- (2- fluoroethyl)- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA 08/2021 - 01/2012
3	Therapeutic UsesIBA 01/2021 - 04/2016
3	Neuroprotective AgentsIBA 01/2021 - 09/2013
3	Radioisotopes (Radionuclides)IBA 01/2021 - 01/2016
3	Phosphotransferases (Kinase)IBA 06/2020 - 06/2012
3	N-methylbenzamideIBA 01/2020 - 09/2013
3	metabotropic glutamate receptor 2IBA 01/2020 - 01/2017
3	ElacridarIBA 02/2019 - 11/2010
3	isobutyric acidIBA 12/2018 - 10/2012
3	Amino Acid Transport Systems (Amino Acid Transporter)IBA 12/2018 - 05/2015
3	arginyl-glycyl-aspartic acidIBA 06/2018 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 09/2017 - 10/2012
3	Monoclonal AntibodiesIBA 03/2015 - 01/2013
3	PropionatesIBA 03/2013 - 04/2005
3	Acetates (Acetic Acid Esters)FDA Link 03/2013 - 04/2005
3	Phosphates (Orthophosphate)IBA 05/2011 - 02/2008
3	Ro 64-0802IBA 05/2011 - 02/2008
2	PolymersIBA 06/2022 - 01/2021
2	EndocannabinoidsIBA 01/2022 - 01/2018
2	Red Fluorescent ProteinIBA 10/2021 - 04/2016
2	64Cu- cyclam- RAFT- cyclo(arginyl- glycyl- aspartyl- phenylalanyl- lysyl)4IBA 12/2020 - 06/2018
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2020 - 01/2017
2	fluoroazomycin arabinosideIBA 08/2020 - 11/2015
2	AMPA Receptors (AMPA Receptor)IBA 01/2020 - 09/2018
2	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 10/2014
2	Amino Acids FDA Link 12/2018 - 02/2016
2	Messenger RNA (mRNA)IBA 12/2018 - 03/2012
2	Annexin A5IBA 08/2018 - 01/2015
2	agerafenibIBA 01/2018 - 08/2014
2	Cholinergic Agents (Cholinergics)IBA 01/2018 - 03/2010

Therapy/Procedure

20	Therapeutics 11/2022 - 04/2009
6	Precision Medicine 01/2021 - 01/2014
6	Radiotherapy 12/2020 - 04/2014
5	Drug Therapy (Chemotherapy) 08/2021 - 06/2010
3	Radioimmunotherapy 05/2022 - 06/2018
2	Intravenous Injections 01/2020 - 05/2011